Sign in

CIK 0001745999

  • Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,193,310
in 2 filings, $1.2M under 10b5-1 plans

Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-01 Bellon Christine Chief Legal Officer Sale 10b5-1 −5,956 $24.58 $146K 109,711
2026-03-31 Bellon Christine Chief Legal Officer Grant or award +20,000 115,667
2026-01-31 Bellon Christine Chief Legal Officer Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-01-22 Bellon Christine Chief Legal Officer Sale 10b5-1 −1,371 $34.00 $47K 95,667
2026-01-15 Bellon Christine Chief Legal Officer Sale 10b5-1 −2,111 $33.62 $71K 113,556
2026-01-15 Bellon Christine Chief Legal Officer Sale 10b5-1 −15,959 $34.72 $554K 97,597
2026-01-15 Bellon Christine Chief Legal Officer Sale 10b5-1 −559 $35.40 $20K 97,038
2025-12-31 Bellon Christine Chief Legal Officer Sale 10b5-1 −1,254 $27.10 $34K 115,667
2025-10-01 Bellon Christine Chief Legal Officer Sale 10b5-1 −373 $24.53 $9K 116,921
2025-04-01 Bellon Christine Chief Legal Officer Sale 10b5-1 −5,674 $18.35 $104K 117,294
2025-03-31 Bellon Christine Chief Legal Officer Grant or award +20,000 122,968
2025-02-14 Bellon Christine Chief Legal Officer Option exercise 10b5-1 +9,492 $7.22 $69K 112,460
2025-02-14 Bellon Christine Chief Legal Officer Option exercise 10b5-1 +508 $7.22 $4K 112,968
2025-02-14 Bellon Christine Chief Legal Officer Sale 10b5-1 −10,000 $34.00 $340K 102,968
2025-02-14 Bellon Christine Chief Legal Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −9,492 0
2025-02-14 Bellon Christine Chief Legal Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −508 10,410
2025-01-31 Bellon Christine Chief Legal Officer Grant or award · Stock Option (Right to Buy) +40,000 40,000
2025-01-02 Bellon Christine Chief Legal Officer Sale 10b5-1 −1,241 $24.68 $31K 102,968
2024-10-01 Bellon Christine Chief Legal Officer Sale 10b5-1 −385 $23.48 $9K 104,209
2024-04-01 Bellon Christine Chief Legal Officer Sale 10b5-1 −3,401 $32.12 $109K 104,594

Page 1 of 2 · 37 trades